Osteomyelitis

Initial Bacterial Seeding and Localization

• The pathogenesis of hematogenous osteomyelitis begins with transient bacteremia, often following minor skin trauma, dental procedures, or infections at distant sites. Bacteria preferentially localize to the metaphysis of long bones in children due to unique vascular anatomy: slow-moving blood flow in the sinusoidal capillaries of the metaphyseal loops creates areas of low oxygen tension and stasis where bacteria readily lodge. In contrast, the cortex has relatively sparse blood supply, and the epiphysis is protected by the avascular cartilage plate. This explains why childhood osteomyelitis classically affects the distal femur, proximal tibia, proximal humerus, and distal radius. In adults, the infection may occur anywhere within the bone marrow, but the vertebral bodies are particularly susceptible due to their rich vascular supply and the presence of Batson's plexus (valveless vertebral venous system) facilitating hematogenous spread.

Bacterial Virulence Factors and Host Invasion

• Staphylococcus aureus, the predominant pathogen in most settings, possesses multiple virulence factors that promote osteotrophism. The enzyme coagulase converts fibrinogen to fibrin, forming a protective biofilm around the bacteria. Protein A binds the Fc portion of immunoglobulins, blocking opsonization and complement activation. Additionally, S. aureus produces α-toxin (alpha-hemolysin), a pore-forming toxin that destroys cell membranes and promotes bacterial survival within osteoblasts and osteocytes. Methicillin-resistant S. aureus (MRSA) strains frequently express Panton-Valentine leukocidin (PVL), a bicomponent toxin that kills neutrophils, thereby impairing the initial immune response. These virulence factors allow S. aureus to not only invade bone but also establish biofilms that render the organism highly resistant to antibiotics and host immune mechanisms.

Inflammatory Cascade and Bone Destruction

• Once bacteria establish infection, the inflammatory response becomes central to pathophysiology. Bacterial products activate pattern recognition receptors (TLRs, NOD-like receptors) on resident macrophages and recruited monocytes, triggering production of TNF-α, IL-1β, and IL-6. These cytokines stimulate RANKL (receptor activator of nuclear factor-κB ligand) expression by infected osteoblasts and T cells. RANKL engagement of RANK receptors on osteoclast precursors leads to osteoclastogenesis and subsequent bone resorption. Simultaneously, bacterial lipopolysaccharide (LPS) and peptidoglycans directly stimulate osteoclast activity. The resulting inflammatory exudate increases intraosseous pressure, further compromising blood supply and creating areas of bone necrosis (sequestra). Dead bone, lacking blood perfusion, becomes a protected nidus for bacterial persistence and becomes sequestered from the body as new periosteal bone forms around it (creating an involucrum). This creates a pathologic situation where antibiotics cannot effectively penetrate necrotic bone because they require adequate blood flow, leading to the chronicity and recurrence seen in untreated or incompletely treated cases.

Transition from Acute to Chronic Osteomyelitis

• Chronic osteomyelitis develops when the inflammatory process evolves to contain necrotic bone, chronic granulation tissue, and sinus tract formation. Biofilm formation by persister bacteria becomes increasingly important in the chronic phase; bacteria within biofilms exhibit reduced metabolic activity and enhanced resistance to antimicrobials—a phenomenon called phenotypic tolerance. In addition, polymicrobial infections become common in chronic osteomyelitis, with anaerobes and Gram-negative organisms supplementing the original S. aureus infection. Chronic infections create a fibrotic capsule around the infected bone, establishing a quiescent but persistent focus that can flare with superinfection or trauma.

Vascular Compromise and Ischemia

• The increased intraosseous pressure from purulent exudation reduces microvascular perfusion within the Haversian and Volkmann canals, creating ischemic necrosis. Areas of necrotic bone become avascular and cannot be reached by systemic antibiotics or immune cells. The periosteum may be elevated by subperiosteal abscess, further compromising cortical blood supply. In contrast to soft tissue infections, the rigid bony architecture prevents free drainage of pus, permitting pressure to accumulate and driving deeper tissue invasion.

Staphylococcus aureus—The Predominant Pathogen

• S. aureus accounts for 50–80% of all osteomyelitis cases across all age groups and clinical scenarios. Both methicillin-sensitive S. aureus (MSSA) and MRSA cause disease with equal frequency in modern practice. MRSA prevalence varies by geography and healthcare exposure; community-acquired MRSA (CA-MRSA) now represents a substantial proportion of both hospital-acquired and community-onset infections. The organism's success in bone infection reflects its ability to produce biofilms, survive intracellularly within osteoblasts, and resist phagocytosis.

Streptococci and Gram-Negative Organisms in Specific Contexts

• Group B Streptococcus (GBS) is common in neonatal osteomyelitis and bacteremia. Streptococcus pneumoniae causes osteomyelitis primarily in children with meningitis or during the pre-vaccine era; today, pneumococcal osteomyelitis is less common but still possible. Gram-negative organisms (particularly Escherichia coli, Klebsiella, Pseudomonas aeruginosa) predominate in specific clinical contexts: neonates (<3 months), IV drug users (especially for vertebral osteomyelitis), patients with neutropenia, and those with urinary tract infections or recent instrumentation. Pseudomonas and other Gram-negatives are also the rule in diabetic foot osteomyelitis, typically as part of polymicrobial infections.

Anaerobes in Polymicrobial Infections

• Peptostreptococcus, Prevotella, Bacteroides, and other anaerobes are isolated in chronic osteomyelitis, diabetic foot infections, and infections complicating human bites. These organisms usually occur alongside aerobic pathogens and reflect the polymicrobial nature of established bone infections.

Unusual Pathogens in Immunocompromised States

• Mycobacterium tuberculosis remains a significant cause of osteomyelitis worldwide, particularly affecting the thoracic and lumbar spine (Pott's disease) and metaphyseal regions of long bones. Fungi (Coccidioides, Blastomyces, Candida) cause osteomyelitis in profoundly immunocompromised hosts (advanced HIV/AIDS, transplant recipients, prolonged neutropenia). Brucella spp. cause chronic osteomyelitis in endemic regions and occupational exposures.

Hematogenous Seeding Risk Factors

• Transient bacteremia from dental procedures, skin infections, urinary tract procedures, cardiac procedures, and endocarditis may seed bone. Children with sickle cell disease have excessively high rates of osteomyelitis due to autoinfarction of the spleen (functional asplenia) and impaired opsonization, combined with bone infarcts that create avascular foci ideal for bacterial seeding. Hemodialysis patients have high rates of S. aureus bacteremia from catheter-related infections, explaining their elevated osteomyelitis risk.

Contiguous Focus and Direct Inoculation

• Diabetic foot ulcers with underlying bone involvement represent the most common source of contiguous osteomyelitis in developed countries. Open fractures with contamination, orthopedic surgery (especially revision procedures), and prosthetic joint infections are major sources of direct inoculation. Pressure ulcers extending into bone are a common problem in immobile patients. Puncture wounds to the foot, classically through rubber-soled shoes and contaminated with Pseudomonas, establish direct osteomyelitis of the tarsal bones.

Prosthetic Joint Infection (PJI)

• Early prosthetic infection (within 3 months of surgery) typically results from intraoperative contamination with skin flora, while delayed prosthetic infection (>3 months) may stem from hematogenous seeding. Late prosthetic infections (>1 year) often involve low-virulence organisms like Propionibacterium acnes and coagulase-negative staphylococci, suggesting reactivation of dormant bacteria or chronic biofilm.

Vertebral Osteomyelitis (Spondylodiscitis)

• This specific form commonly follows bacteremia from GU or GI sources, endocarditis, IV drug use, and spinal procedures. S. aureus remains most common, but Gram-negatives and anaerobes occur more frequently than in appendicular osteomyelitis. Tuberculosis remains an important cause globally.

Immunosuppression and Chronic Disease

• Diabetes mellitus dramatically increases osteomyelitis risk, particularly in the context of neuropathic foot ulcers (up to 50% of chronic diabetic foot ulcers develop underlying osteomyelitis). HIV/AIDS with CD4 <50 cells/μL increases risk of Mycobacterium avium complex and fungal osteomyelitis. Neutropenia (<500 cells/μL) predisposes to invasive infections including osteomyelitis. Chronic kidney disease and dialysis increase S. aureus bacteremia risk. Rheumatoid arthritis patients on TNF inhibitors face increased osteomyelitis risk due to impaired immune responses.

Acute Hematogenous Osteomyelitis in Children—Classic Presentation

• Acute-onset fever, systemic toxicity, and focal bone pain constitute the classic triad. Fever is typically high (>38.5°C) and accompanied by chills, malaise, and anorexia. Localized bone pain is severe and disproportionate to physical findings; the pain is exacerbated by movement and weight-bearing. The child frequently refuses to bear weight or move the affected limb (pseudoparalysis), creating an appearance of severe dysfunction despite absence of true neurological deficit. This dramatic reduction in mobility reflects severe pain and possible early septic arthritis (if the infection breaches the growth plate). Swelling, erythema, and warmth over the involved metaphyseal region appear later (24–72 hours) as the inflammatory exudate expands through the periosteum. The metaphysis of long bones (distal femur > proximal tibia > proximal humerus) shows predilection due to the vascular anatomy described previously. Systemic signs predominate early; local signs evolve over days.

Acute Osteomyelitis in Adults—Subacute Presentation

• Adults often present insidiously with weeks of deep, aching bone pain rather than the acute toxic presentation seen in children. Constitutional symptoms (fever, night sweats, malaise) may be mild or absent. Localized swelling and erythema develop gradually. The clinical picture is frequently complicated by the presence of underlying chronic disease (diabetes, vascular insufficiency, renal disease), which may mask systemic signs and delay diagnosis. In vertebral osteomyelitis, patients present with progressive back pain (often worse at night and unrelieved by rest), sometimes with radiculopathy or myelopathy if epidural abscess develops.

Diabetic Foot Osteomyelitis—Often Occult

• Patients with neuropathy may be entirely unaware of underlying osteomyelitis, discovering it only after a foot ulcer fails to heal or becomes gangrenous. Absence of fever is common despite bone infection, reflecting the chronic nature of the process. Malodorous discharge, violaceous discoloration, and signs of cellulitis or tissue necrosis may be present. The risk of amputation is substantial if infection is not recognized.

Physical Examination Findings

• Point tenderness over the metaphysis, elicited by percussion or palpation, is highly suggestive of osteomyelitis. Swelling and erythema of overlying skin and soft tissues develop as the infection progresses. Warmth over the affected bone reflects increased inflammatory activity. Range-of-motion restriction occurs secondarily to pain. Signs of sepsis (tachycardia, tachypnea, hypotension, altered mental status) may be evident in acute cases with systemic toxicity. Draining sinuses with purulent discharge indicate chronic osteomyelitis or transition to the chronic phase. Overlying skin ulceration or gangrene is characteristic of diabetic foot osteomyelitis.

Important Clinical Variants

• Brodie's abscess: A subacute form of osteomyelitis presenting with chronic localized bone pain and minimal systemic symptoms; a well-demarcated intraosseous abscess evident on imaging; may smolder for months before diagnosis.
• Acute suppurative arthritis coexisting with osteomyelitis: If metaphyseal infection breaches the joint capsule (when the growth plate does not completely separate the metaphysis from the joint cavity, as in the proximal femur and humerus), septic arthritis develops simultaneously, requiring urgent drainage.
• Chronic osteomyelitis with sinus tract formation: After months to years, chronic drainage through a sinus tract to skin becomes established; recurrent drainage, malodor, and episodes of cellulitis are typical.

Clinical History and Physical Examination

• A high index of suspicion is essential, as early diagnosis dramatically improves outcomes. Obtain detailed history of antecedent trauma, surgery, dental procedures, fever, or infection at distant sites. In diabetic patients, inquire about foot care, trauma, and ulcer duration. Physical examination should include careful palpation for bony tenderness, assessment of warmth and erythema, and evaluation for overlying skin breakdown. Failure of an infected wound or ulcer to improve after 7–14 days of appropriate antibiotic therapy suggests underlying osteomyelitis.

Laboratory Studies

• CBC with differential: Leukocytosis (WBC typically 12,000–20,000/μL) with left shift occurs in acute infection; chronic infection may show normal or only mildly elevated WBC.
• Erythrocyte sedimentation rate (ESR): Markedly elevated (often >30 mm/h) in acute osteomyelitis; sensitivity approaches 90% but specificity is poor (elevated in many inflammatory conditions). ESR is also useful for monitoring response to therapy.
• C-reactive protein (CRP): More rapidly responds to infection (peaks at 24–48 hours) than ESR; increases rapidly and normalizes more quickly than ESR; useful for tracking therapeutic response.
• Blood cultures: Positive in 50–60% of acute hematogenous osteomyelitis; essential for organism identification and antimicrobial susceptibility testing. Obtain 2–3 sets before initiating antibiotics in febrile patients.
• Bone culture and biopsy: The gold standard for diagnosis, obtained via open surgical biopsy or percutaneous needle biopsy under imaging guidance. Culture sensitivity varies (sensitivity ~80–90% depending on prior antibiotic exposure) and is essential for identifying organism and determining antimicrobial susceptibility. Histologic examination may show suppurative inflammation, necrotic bone, and chronic inflammatory infiltrates (depending on chronicity).

Imaging Studies—Critical for Diagnosis and Staging

Immediate stabilisation

• Sepsis or neurologic compromise: resuscitate, draw two to three blood culture sets, and start empiric antibiotics without delay. Spinal epidural abscess with motor deficit and septic arthritis of a native joint are surgical emergencies — decompression/drainage must not wait for culture data.
• Hemodynamically stable patients: the IDSA native vertebral osteomyelitis guideline advises withholding empiric antibiotics until image-guided bone biopsy or blood cultures identify the organism, because bone infection requires weeks of pathogen-directed therapy and pretreatment sterilises cultures.

Empiric therapy (culture pending)

• Anti-MRSA agent: vancomycin, dosed to a 24-hour AUC with an AUC/MIC target of 400–600 (2020 IDSA/ASHP consensus); trough-only targeting has been retired. Daptomycin or linezolid are alternatives.
• Add gram-negative coverage (third/fourth-generation cephalosporin such as ceftriaxone or cefepime) when the source is genitourinary, in injection drug users, or in diabetic foot disease; piperacillin-tazobactam or cefepime covers Pseudomonas after plantar puncture wounds.
• Neonates are the exception: use an antistaphylococcal agent plus cefotaxime (or an aminoglycoside such as gentamicin). Ceftriaxone is contraindicated in neonates — it displaces bilirubin from albumin (kernicterus risk) and precipitates with calcium-containing IV solutions.

Definitive pathogen-directed therapy

• MSSA: antistaphylococcal penicillin (nafcillin) or cefazolin — both outperform vancomycin for susceptible strains.
• MRSA: vancomycin or daptomycin.
• Duration is prolonged, typically about six weeks from the last debridement for adult native bone and vertebral infection (IDSA). Oral step-down with highly bioavailable agents is supported by the OVIVA trial; children with uncomplicated hematogenous disease are routinely transitioned to oral therapy after clinical and CRP improvement.
• Retained hardware/prosthetic joint infection: IDSA recommends adding rifampin to a companion agent (commonly a fluoroquinolone) for staphylococcal infection because it penetrates biofilm — never as monotherapy, which rapidly selects resistance.

Surgical management

• Debridement of sequestrum and necrotic bone, drainage of abscess, dead-space management, revascularisation of the ischemic diabetic foot, and hardware removal or two-stage exchange arthroplasty. Antibiotics cannot sterilise avascular bone or biofilm.

Avoid

• Sinus-tract or superficial wound swabs to direct therapy — they correlate poorly with deep bone isolates, and even a swab growing S. aureus has only modest positive predictive value. Deep bone culture remains required to direct definitive therapy.
• Rifampin monotherapy; empiric therapy in the stable patient before biopsy.

Local complications of infection

• Chronic osteomyelitis: persistence of avascular sequestrum walled off by involucrum; signalled by relapsing pain, a chronically draining sinus tract, and imaging showing devitalised bone. Antibiotics alone will fail — surgical debridement is required.
• Pathologic fracture: osteoclast-mediated resorption plus necrosis weakens the cortex; sudden pain, deformity, or new inability to bear weight after apparent improvement.
• Septic arthritis: metaphyseal infection breaches an intracapsular metaphysis (proximal femur, proximal humerus) into the joint. A hot, held-still joint with effusion is an emergency — arthrocentesis then urgent drainage; cartilage is destroyed within days.
• Growth disturbance in children: physeal involvement causes limb-length discrepancy or angular deformity, often apparent only on follow-up.

Systemic and delayed complications

• Bacteremia, endocarditis, metastatic abscess: echocardiography is indicated in S. aureus bacteremia generally; persistent bacteremia beyond 48–72 hours of appropriate therapy mandates transesophageal echocardiography and a search for undrained foci.
• Spinal epidural abscess: contiguous extension in vertebral osteomyelitis; emergency — new radicular pain, weakness, or bowel/bladder dysfunction mandates immediate MRI and neurosurgical decompression.
• Amputation: the dominant outcome measure in diabetic foot osteomyelitis, driven by ischemia plus uncontrolled infection.
• Marjolin ulcer: squamous cell carcinoma arising in a long-standing sinus tract; new heaped-up edges, bleeding, or a change in drainage warrants biopsy.
• Secondary (AA) amyloidosis: chronic serum amyloid A elevation; presents with proteinuria/nephrotic syndrome.

Treatment-related complications

• Vancomycin: acute kidney injury, potentiated when combined with piperacillin-tazobactam; infusion-related flushing reaction from histamine release.
• Daptomycin: rising CPK/myopathy — monitor weekly; rarely eosinophilic pneumonia.
• Linezolid: dose- and duration-dependent myelosuppression (thrombocytopenia), peripheral and optic neuropathy, serotonin syndrome with SSRIs.
• Rifampin: potent CYP450 induction (warfarin, oral contraceptive failure), hepatotoxicity, orange body fluids.
• Prolonged IV access: catheter-related bloodstream infection and venous thrombosis; Clostridioides difficile colitis from any prolonged course.

• ***Staphylococcus aureus* is the single most common cause of osteomyelitis overall and in most settings. Notable exceptions: late prosthetic joint infection**, dominated by coagulase-negative staphylococci and Cutibacterium (Propionibacterium) acnes. In sickle cell disease, Salmonella is disproportionately overrepresented and is the classic exam answer, though the relative frequency of Salmonella versus S. aureus varies between published series. Read the stem for which question is actually being asked.
• Plain radiographs are normal early. Periosteal reaction and lytic change require substantial bone mineral loss and lag one to two weeks. A normal film never excludes osteomyelitis — MRI is the best next imaging step for early or occult disease (marrow edema, abscess, epidural extension).
• Bone biopsy with culture is the diagnostic gold standard and the single best next step in a stable patient before antibiotics. Common distractor: sinus tract or ulcer swab culture — superficial swabs correlate poorly with deep bone isolates, and even a swab growing S. aureus has only modest positive predictive value; deep bone culture is still required to direct definitive therapy.
• **Puncture wound through a rubber-soled shoe → *Pseudomonas aeruginosa* osteomyelitis of the foot. Human/animal bite → polymicrobial with anaerobes and *Eikenella*/*Pasteurella*. Child under 4 with culture-negative bone or joint infection → Kingella kingae.**
• Diabetic foot ulcer: a positive probe-to-bone test plus a large or deep ulcer, exposed bone, or a markedly elevated ESR strongly predicts underlying osteomyelitis (IDSA/IWGDF).
• Vertebral osteomyelitis destroys the disc space and crosses it to involve two adjacent vertebral bodies; metastatic disease spares the disc. Back pain worse at night plus fever plus elevated inflammatory markers should trigger MRI.
• Pott disease — tuberculous spondylitis of the thoracolumbar spine with gibbus deformity and cold psoas abscess. Brodie abscess — walled-off subacute intraosseous abscess with a sclerotic rim and minimal systemic signs.
• MSSA is treated with nafcillin or cefazolin, not vancomycin; vancomycin is inferior for susceptible strains and is dosed to AUC/MIC 400–600, not to a 15–20 mcg/mL trough.